Aqr Capital Management LLC Karuna Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$164.66 - $218.08 $192,487 - $254,935	-1,169 Reduced 22.25%	4,084 $690,000
Q2 2023 Aug 14, 2023	SELL	$176.32 - $240.22 $104,910 - $142,930	-595 Reduced 10.17%	5,253 $1.14 Million
Q1 2023 May 15, 2023	SELL	$161.33 - $204.36 $1.15 Million - $1.45 Million	-7,118 Reduced 54.9%	5,848 $1.06 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $250,521 - $309,760	1,308 Added 11.22%	12,966 $2.55 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $1.13 Million - $2.54 Million	9,145 Added 363.91%	11,658 $2.62 Million
Q2 2022 Aug 15, 2022	BUY	$93.97 - $143.33 $236,146 - $360,188	2,513 New	2,513 $318,000
Q1 2021 May 17, 2021	SELL	$95.46 - $133.08 $272,729 - $380,209	-2,857 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$75.23 - $109.23 $214,932 - $312,070	2,857 New	2,857 $290,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.